Finzati - Logo
WST logo

West Pharmaceutical Services, Inc.

WST • Medical - Instruments & Supplies
$339.97
▼ -2.76 (-0.81%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$24.24B
Growth
6.8%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 16.1%Positive free cash flow · 6.49Consistent free cash flow · 5/5Manageable debt level · 0.13Healthy liquidity · 3.02
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$339.97
Change-0.81%
Shares Out71.30M
Market Cap$24.24B
Enterprise Value$24.12B
52W Range223.83 - 386.00
Beta1.16
P/E42.91
P/S7.29
P/B8.11
P/FCF55.48
EV/Sales7.25

Investment DNA

How strong this company looks for long-term investors

71
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
68/100
Price Attractiveness
Cheap or expensive today
34/100
Why this score▼
Stable or improving margins · 16.1%Positive free cash flow · 6.49Consistent free cash flow · 5/5Manageable debt level · 0.13Healthy liquidity · 3.02Expensive earnings multiple · 40.29

Analyst view

Analyst sentiment and price target

WST
Analyst sentiment
Based on 16 analyst votes · 2026-09-05
84/100
Bullish
Bullish
12
Hold
3
Bearish
1
Price Target
2026-07-24
Low
$295.00
Mean
$370.25
Median
$377.50
High
$447.00

Company Overview

IPO: 3/17/1980
Industry: Medical - Instruments & Supplies
P/B i: 8.11
Debt / Equity i: 0.13
Operating Margin: 20.09%
Net Margin: 16.06%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.13
Current Ratio: 3.02
Quick Ratio: 2.34
Status: Strong

Insider Transactions

Recent executive and insider activity

HAUGEN JANET BRUTSCHEA
Transaction: 06/30/2026
BUY
Change
+46
Price
Not reported
Filing
07/01/2026
Type
BUY
Campbell Shane Alden
Transaction: 05/12/2026
SELL
Change
—
Price
$312.07
Filing
05/14/2026
Type
SELL
Campbell Shane Alden
Transaction: 05/12/2026
SELL
Change
—
Price
Not reported
Filing
05/14/2026
Type
SELL